Previous Close | 2.4300 |
Open | 2.5500 |
Bid | 0.0000 x 4000 |
Ask | 0.0000 x 2200 |
Day's Range | 2.4550 - 2.6100 |
52 Week Range | 1.9100 - 8.7600 |
Volume | |
Avg. Volume | 86,014 |
Market Cap | 12.498M |
Beta (5Y Monthly) | 1.55 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.4180 |
Earnings Date | Aug 10, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 12.25 |
Subscribe to Yahoo Finance Plus to view Fair Value for YTEN
WOBURN, Mass., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its second quarter 2022 financial results and provide a corporate update on Wednesday, August 10, 2022. Management will host a conference call on Wednesday, August 10, 2022 at 4:30 p.m. ET to review financial results, share corporate highlights, and provide an overall business update. Following manag
WOBURN, Mass. and SASKATOON, Saskatchewan, July 12, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10 Bioscience” or the “Company”), an agricultural bioscience company, today announced the name change of its wholly-owned Canadian subsidiary to Yield10 Oilseeds Inc. from Metabolix Oilseeds, Inc. effective July 12, 2022. This name change creates an alignment of Yield10 Bioscience’s Canadian subsidiary with the branding associated with the Yield10 Bioscience business, which
Archer Daniels Midland, Corteva, Yield10 Bioscience, Adecoagro and Calavo Grower have been highlighted in this Industry Outlook article.